|
Match
|
Document |
Document Title |
|
|
5458886 |
Antifoam compositions
Free-flowing granular compositions principally for use in treatment of gastric disorders comprise (A) titanium dioxide having a particle size within the range from 10 nanometers to 60 nanometers...
|
|
|
5437873 |
Superior tasting pharmaceutical composition having porous particles and the process of preparing such pharmaceutical composition
The present invention is directed towards a process for producing a superior tasting pharmaceutical composition having porous granules produced through in situ gas generation using...
|
|
|
5431920 |
Enteric coated oral compositions containing bisphosphonic acid antihypercalcemic agents
The present invention relates to a novel oral dosage form of a bisphosphonic active ingredient for use in treatment of diseases involving bone resorption and formulated in an enteric-coated form...
|
|
|
5417986 |
Vaccines against diseases caused by enteropathogenic organisms using antigens encapsulated within biodegradable-biocompatible microspheres
This invention is directed to oral parenteral and intestinal vaccines and eir use against diseases caused by enteropathogenic organisms using antigens encapsulated within...
|
|
|
5399360 |
Pharmaceutical compositions
A ketotifen pharmaceutical composition adapted for once-a-day oral administration e.g. based on a fat matrix.
|
|
|
5387421 |
Multi stage drug delivery system
A drug delivery system includes a first capsule half having an inner chamber for containing a drug therein. A plug is disposed in a passageway of the capsule half for plugging the opening thereof....
|
|
|
5382601 |
Memantine-containing solid pharmaceutical dosage forms having an extended two-stage release profile and production thereof
The present invention provides solid pharmaceutical compositions in dosage form containing an active ingredient or principle, preferably memantine, which exhibit an extended two-phase release...
|
|
|
5376382 |
Tablets, granulates and pellets with a high active substance content for highly concentrated, solid dosage forms of thioctic acid
A solid medicinal form having an active substance content of over 45 weight % and processes for its preparation by granulating with large amounts of water, drying and optionally conventional...
|
|
|
5370878 |
Method for preparing a direct compression granulated acetaminophen composition
A direct compression granulated acetaminophen tableting composition is prepared by blending acetaminophen with a binder, disintegrant, lubricant and a small amount of water or alcohol, compacting...
|
|
|
5370880 |
Pharmaceutical formulations containing acrivastine
The invention relates to a controlled release pharmaceutical formulation for oral administration which comprises discrete units comprising acrivastine or a salt thereof coated with a mixture...
|
|
|
5342627 |
Controlled release device
The invention relates to a device for the release of at least one active substance (e.g. ranitidine) into a fluid medium by dissolution comprising a covering, which is impermeable to the active...
|
|
|
5334393 |
Sustained-release tablet based on isosorbide 5-mononitrate and process for preparing it
The present invention relates to a sustained-release tablet, characterized in that it comprises as active principle isosorbide 5-mononitrate (5-ISMN) in the form of a powder having a particle size...
|
|
|
5330761 |
Bioadhesive tablet for non-systemic use products
The present invention relates to a controlled release bioadhesive tablet which includes a locally active agent, a heterodisperse gum matrix, and a pharmaceutically acceptable diluent. In certain...
|
|
|
5326572 |
Freeze-dried polymer dispersions and the use thereof in preparing sustained-release pharmaceutical compositions
Freeze-dried polymer latices, which can be reconstituted in water to give aqueous polymer dispersions having high polymer solids content, are described. The reconstituted polymer dispersions are...
|
|
|
5322694 |
Pharmaceutical lozenges
The present invention is directed to gelatin treated polyhydric alcohol compositions, their preparation, and to pharmaceutical lozenges prepared therefrom. The pre-granulation of a polyhydric...
|
|
|
5320852 |
Antacid microtablets
A biconvex tablet whose height and diameter are approximately equal and are from 1.5 to 4 mm and which, besides conventional pharmaceutical auxiliaries, contains an antacid as active substance is...
|
|
|
5314697 |
Stable extended release oral dosage composition comprising loratadine and pseudoephedrine
A film-coated extended release oral dosage composition containing the nasal decongestant pseudoephedrine sulfate in a unique polymer matrix core and a film-coating on such core containing the...
|
|
|
5288506 |
Antacid compositions with prolonged gastric residence time
Antacid powders, tablets etc. of prolonged gastric residence time have an internal phase of a solid antacid and excipient surrounded by a solid external phase containing a hydrophobic substance...
|
|
|
5277916 |
Tetracycline dosage form
A tetracycline pharmaceutical composition having a core element containing a tetracycline antibiotic and a core coating which dissolves more slowly in the stomach than in the intestine....
|
|
|
5275819 |
Drug loaded pollen grains with an outer coating for pulsed delivery
A pulsating release composition comprising natural microspheres, such as pollen grains or spores, into which are loaded a biologically active is subsequently releasable therefrom in a predetermined...
|
|
|
5275825 |
Compressed-molded preparations
Compressed molded preparations are disclosed. In the preparation coated granules of a pharmaceutical composition are compressed and molded together with non-coated component(s) containing 10% or...
|
|
|
5268182 |
Sustained-release drug dosage units of terazosin
A sustained-release coating composition is described that contains an ethylcellulose and/or a methacrylic methylester together with a plasticizer and a detackifying agent. Sized drug granules are...
|
|
|
5268181 |
Method of using niacin to control nocturnal cholesterol synthesis
The invention provides a therapeutic method to treat hyperlipidemia by administering to a human patient a single daily dose of a prolonged release dosage form of niacin, so that nocturnal...
|
|
|
5262169 |
Tablets and granulates containing mesna as active substance
A granulate containing mesna is made by granulating mesna in the presence of an alcohol, acetone or a mixture of one of these with water. The granulate may be converted to tablets, along with other...
|
|
|
5260304 |
Pharmaceutical preparation binding with gastric acid
Granules, possibly pressed into the form of tablets, contain at least one insoluble, complexed or slightly soluble active substance in powder form which can bind or neutralize acids and which does...
|
|
|
5248700 |
Active agent containing solid structures for prolonged release of active agents
A solid mixture of a degradable polymer (B) in which an active agent loaded microporous powder or granulate form polymer (A) is uniformly dispersed. The active agent loaded polymer (A) is...
|
|
|
5240662 |
Process for the preparation of solid pharmaceutical compositions
The invention relates to a process for the preparation of solid pharmaceutical compositions. More specifically, the invention relates to a process for the preparation of tablets ensuring an...
|
|
|
5229135 |
Sustained release diltiazem formulation
A sustained release diltiazem formulation for oral administration comprising a pellet having a central sugar sphere a plurality of alternating first and second layers surrounding the sphere to form...
|
|
|
5225197 |
Pharmaceutical formulation
A chewable tablet comprises a medicament dispersed in a chewable base, such as mannitol, together with an effervescent couple, such as citric acid - sodium bicarbonate. The combination of...
|
|
|
5217719 |
Surface-treated sodium bicarbonate particle and molded preparation thereof
Surface-treated sodium bicarbonate particles, the surfaces of which are coated with sodium carbonate or its double salt, are disclosed. Heat treatment or irradiation with micro waves o infrared...
|
|
|
5215752 |
Pharmaceutical tablets and capsule granulates of scleroglucan and active substance
Pharmaceutical tablets and capsule granulates for oral administration, with controlled release of the active substance, comprising scleroglucan and active substance and pharmaceutical acceptable...
|
|
|
5211958 |
Pharmaceutical composition and process for its preparation
A multi-purpose pharmaceutical tablet which can either be readily swallowed or dissolved in water to give a dispersion, comprising a tetracycline, microcrystalline cellulose or microfine cellulose,...
|
|
|
5211957 |
Solid rapidly disintegrating dosage form
The invention relates to a solid, rapidly disintegrating dosage form in the form of effervescent tablets for producing an aqueous suspension of diclofenac for peroral administration. The dosage...
|
|
|
5204115 |
Directly compressible xylitol and method
A directly compressible xylitol granulate comprising xylitol and a physiologically acceptable, non-cariogenic binder taken from the group consisting of polymerized reducing sugars, an alkali...
|
|
|
5200193 |
Pharmaceutical sustained release matrix and process
A pharmaceutical sustained release homogeneous tablet or homogeneous tablet layer is formed by making a wet granulation using povidone (PVP) in alcohol as the granulating fluid which is mixed with...
|
|
|
5198228 |
Direct dry compressible acetaminophen tablet
This invention relates to an analgesic composition and more particularly, to a directly dry compressible composition comprising at least about 70% by dry weight of the composition of acetaminophen...
|
|
|
5196184 |
Pharmaceutical preparation
Pharmaceutical preparation containing Nifedipin as the active substance together with a solution promoter, such as, for example, copolyvidon or polyvinylpyrrolidone and/or...
|
|
|
5169639 |
Controlled release verapamil tablets
Controlled release verapamil tablets are disclosed. The tablets include an excipient having a hydrophilic material, preferably containing a mixture of xanthan gum/locust bean gum, and an inert...
|
|
|
5164380 |
Process for preparing piroxicam/cyclodextrin complexes, the products obtained and their pharmaceutical compositions
A process for preparing complexes of piroxicam with cyclodextrins in which the two components in the powder state are premixed and then co-ground in a high energy mill in the presence of steam. The...
|
|
|
5160742 |
System for delivering an active substance for sustained release
A system for delivering an active substance has sustained release of the active substance in the intestinal tract. This delivery system is especially useful for an active substance such as a...
|
|
|
5153002 |
Biocompatible gradient controlled release implant
A biocompatible and/or biodegradable implant for the substantially constant release, by diffusion, of a therapeutic agent in the outside medium at the site of implant which comprises a body...
|
|
|
5149542 |
Coating membrane and compositions prepared therefrom
Controlled release pellets consisting of an inert material, a medicament layer and a coating membrane of a mixture or stearic acid and ethyl cellulose or of parrafin and methacrylic acid copolymer.
|
|
|
5147646 |
Hydrogel containing envelopes
An envelope having flexible water-permeable or porous walls contains a quantity of particulate water-insoluble hydrogel. The quantity of hydrogel in the envelope is such that, when the hydrogel is...
|
|
|
5137730 |
Tablet composition and method for problem pharmaceutical materials using citric acid
In accordance with the present invention an improved tablet composition for drugs or active ingredients prone to poor tabletting properties is disclosed. The improved composition comprises a...
|
|
|
5135757 |
Compressible sustained release solid dosage forms
A free-flowing directly compressible granulation useful as a slow release pharmaceutical excipient is disclosed. The excipient includes a hydrodrophilic matrix which includes heteropolysaccharide...
|
|
|
5132116 |
Tablets of the hydrophilic matrix type based on salbutamol and a process for their preparation
The present invention relates to tablets of the type which contain a homogeneous dispersion of an active principle based on salbutamol or on one of its derivatives in a hydrophilic matrix,...
|
|
|
5130140 |
Method of making direct dry compressible acetaminophen composition
This invention relates to an analgesic composition and more particularly, to a directly dry compressible composition comprising at least about 70% by dry weight of the composition of acetaminophen...
|
|
|
5128143 |
Sustained release excipient and tablet formulation
A slow release pharmaceutical excipient of an inert diluent and a hydrodrophilic material including xanthan gum and a galactomannan gum capable of cross-linking the xanthan gum in the presence of...
|
|
|
5126145 |
Controlled release tablet containing water soluble medicament
A sustained or controlled release tablet is disclosed. The tablet comprises a water soluble medicament, a hydroxypropyl methylcellulose having sustaining action, a pharmaceutical binding agent, and...
|
|
|
5116619 |
Vaginal progesterone tablet
A vaginal progesterone suppository is provided in the form of a tablet which delivers biologically effective amounts of progesterone for at least about 48 hours, and blood amounts above basal...
|